about
Recent advances in treatment of heart failureAgents with vasodilator properties in acute heart failure: how to design successful trialsRelaxin Treatment in an Ang-II-Based Transgenic Preeclamptic-Rat ModelPeripartum cardiomyopathy: challenges in diagnosis and management.Pregnancy impairs baroreflex control of heart rate in rats: role of insulin sensitivityRelaxin: review of biology and potential role in treating heart failure.Impact of the estrus cycle and reduction in estrogen levels with aromatase inhibition, on renal function and nitric oxide activity in female rats.Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS.Identification and optimization of small-molecule agonists of the human relaxin hormone receptor RXFP1.Angiogenic growth factors are new and essential players in the sustained relaxin vasodilatory pathway in rodents and humansRelaxin regulates vascular wall remodeling and passive mechanical properties in mice.Reduced NO signaling during pregnancy attenuates outward uterine artery remodeling by altering MMP expression and collagen and elastin depositionNew Drugs You Are Going to Read About: Serelaxin, Ularitide, TRV027.Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsiaUnveiling the vasodilatory actions and mechanisms of relaxinRelaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study.Relaxin, a pleiotropic vasodilator for the treatment of heart failure.Localization of relaxin receptors in arteries and veins, and region-specific increases in compliance and bradykinin-mediated relaxation after in vivo serelaxin treatmentMedical therapy for acute decompensated heart failure: what recent clinical trials have taught us about diuretics and vasodilators.Hanging in the balance: endogenous anti-inflammatory mechanisms in tissue repair and fibrosis.Novel vasodilators in heart failure.Novel pharmacologic therapies in development for acute decompensated heart failure.Relaxin: new pathophysiological aspects and pharmacological perspectives for an old protein.Pregnancy, cardiomyopathies, and genetics.Novel drug mechanisms in development for heart failure.Serelaxin : a potential new drug for the treatment of acute heart failure.Relaxin: a novel agent for the treatment of acute heart failure.Emerging Therapies for Acute and Chronic Heart Failure: Hope or Hype?Relaxin' the Heart: A Novel Therapeutic Modality.Identification of recombinant human relaxin-2 in equine plasma by liquid chromatography-high resolution mass spectrometry.Relaxin-mediated renal vasodilation in the rat is associated with falls in glomerular blood pressure.
P2860
Q26766223-F3AA23AE-0272-4F9C-9635-AA91B77239DFQ28084239-DAD2DCF0-1218-4D5B-9B99-53EEA0A82D9FQ28550653-931D6539-C1AC-49B7-9740-7521255BB833Q33363307-50D181BD-4122-449F-9495-64B23579753CQ33686616-0E83486D-C39A-48CD-AE28-FCACA440AA02Q33873275-D26A4D8E-872D-4CBA-877C-78F15E3F7D32Q34079657-3DF94BE2-F5FC-40F7-A91F-3AE9E3FE0E49Q34398874-6F802BE4-2D66-4970-A2D9-B9AEFB59289EQ34771756-C5A8FB1C-68CE-4E4E-BE78-FDDBE34C29CEQ35042471-6139E6C1-9A00-48C1-8A01-D00FBB8C5983Q35108756-5FE11753-40F8-4ECB-A2E0-BB6B5509086DQ35395483-2DDD97BF-5CB0-4261-BE66-A9A34ECAE916Q35899860-61762402-1723-416C-A815-3471F894E64BQ36054390-38458C63-CAFE-4859-9582-522C66605944Q36084530-E92AE39A-37B1-45C6-BA55-36F9B5428DD8Q36853140-55221C6D-D14C-4859-92CE-6C55BA14576FQ37356318-33902886-86C4-4C24-A4C3-B2F109E47BD8Q37405208-F356DAF8-0A05-4ACF-AC63-3910A7F1681AQ37923340-C733676D-B6FC-4718-9E9F-5378FD99AC21Q38046124-3AF03ACD-68F2-4F8D-AA1D-169889609FCDQ38072635-3A8FCB09-691E-4C8C-B159-7C0BA054A9F1Q38073647-EFF7024C-B252-4196-AF7D-452A0D12D3ECQ38080804-D388C7BF-34E6-4536-96E3-AB525FCA36FAQ38180838-15A78CB6-73C0-4075-AEAE-35E4C90899F2Q38209074-E038F432-642D-4AE6-8DE1-BE4EB176A118Q38215304-27789CC0-9499-44D5-91E3-48843CCBA4D2Q38373223-D4F0E0C8-3B8C-484C-B4BF-FBB13348EB23Q38694200-8E9DAD25-D551-455E-B7CE-5A99C6A5A3D7Q38940630-2FADE33B-E3DC-49D5-810B-1A3243BD4148Q45718465-D7106562-6576-48B0-9319-6F39ED88C792Q50091258-AD08F65D-D32C-4033-8F97-F8E0BFD99FB0
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The vascular actions of relaxin.
@en
The vascular actions of relaxin.
@nl
type
label
The vascular actions of relaxin.
@en
The vascular actions of relaxin.
@nl
prefLabel
The vascular actions of relaxin.
@en
The vascular actions of relaxin.
@nl
P2093
P1476
The vascular actions of relaxin.
@en
P2093
Arundhathi Jeyabalan
Jaqueline Novak
Kirk P Conrad
Sanjeev G Shroff
P356
10.1007/978-0-387-74672-2_6
P407
P577
2007-01-01T00:00:00Z